How do Forecasting Approaches and Methodologies Change Through the Product Lifecycle?
Pharma forecasting is not a “one and done” activity. The life of a drug – from a glint in the clinician’s eye, to an established therapy heading towards loss of exclusivity – is a long and complex one. And forecasting for each stage of that lifecycle is very different. In this short video, I highlight […]
Highlights of the Orphan Drugs Report by its Creators
For the past few years, Melanie Senior and Andreas Hadjivasiliou have worked together to deliver Evaluate’s annual Orphan Drugs report. They charted the rise and rise of drugs for rare diseases, and discussed the ever-changing market landscape for this fascinating, high risk and hugely important corner of the pharmaceutical industry. In this short video, Melanie […]
How We Build the Analysis Behind Our Orphan Drugs Report
How do we Create the Analysis for our Orphan Drugs Report? Insight is the cornerstone of our annual orphan drugs report, and all that insight and analysis starts with the enormous wealth of data within Evaluate Pharma. If you’ve ever wondered how we build out all this analysis, you’re in luck! In this super-short video, […]
How Can Analogs Help Pharma Companies Forecast Effectively?
When you’re bringing a new drug to market, one of the many forecasting challenges is the ability to root your forecasts in reality. This is where analogs come in. Analogs are a really powerful forecasting tool and by selecting a suite of analogs can enable forecasters to take the past and use it as a […]
What’s the role of Excel in a Forecaster’s Software Toolkit?
There are many challenges that biopharma forecasters face but perhaps one of the greatest is asking people to change their behavior. No matter how many fancy forecasting tools and solutions you may have, people know what they like and one thing they like is Excel. In this video, I talk about why there is still […]
